China gives green light to 2 home-grown Covid-19 antiviral treatments

• The approval comes during reprieve from tsunami of infections but another wave could be on the way after Lunar New Year migration
• The approved medications include China’s first antiviral to use the same approach as Pfizer’s Paxlovid